Mephenoxalone (1) was synthesized through a silanizated intermediate prepared from the addition of trimethylsilyl cyanide (TMSCN) to (o-methoxy)phenoxyacetaldehyde (10). Three different methods were established to synthesize this aldehyde. Alkylation of guaiacol with bromoacetaldehyde diethyl acetal, followed by acid hydrolysis of acetal group gave the highest overall yield (49%) for the aldehyde 10. Different reagents as ZnI 2 , Montmorillonite K10, (+)-Eu(tfc) 3 and (+)-Yb(tfc) 3 were used in the addition of TMSCN to the aldehyde giving very good yields with all catalysts.
Introduction
Oxazolidinone compounds are important because their broad spectra of pharmacological properties. Especially, 5-aryloxymethyl-2-oxazolidines are a group of compounds which shown activity as interneuron blocking agents or depressants of central synaptic transmission. They are generally antagonists of strychnine convulsions and have been used as skeletal muscle relaxants, anticonvulsants, and tranquilizers. Mephenoxalone (Tripedone®) (1) is a skeletal muscle relaxant as well as anxiolytic, and Metaxalone (2) is a skeletal muscle relaxant, it acts in the central nervous system to produce the muscle relaxant effects and it is currently commercially available in the U. S. under the trend name of Skelatin®. 1 These products are indicated as an adjunct to rest, physical therapy, and other measures for relief of discomforts associated with acute, painful musculoskeletal conditions. [2] [3] [4] [5] [6] In the other hand, another group of oxazolidinones typified by Eperozolid (3) and Lynezolid (4) (marketed as Zyvox TM ), represent a new class of synthetic antibacterial agents with potent activity against clinically important susceptible and resistant Gram-positive pathogens. This class of compounds has a novel mechanism of action that shows selective and unique binding to 50S ribosomal subunit, inhibiting bacterial translation at initiation phase of protein synthesis. 7 It is suggested that oxazolidinones act by disrupting the processing of N-formylmethionyl t-RNA by the ribosome.
The synthesis of Mephenoxalone was reported by Lunsford in 1960. 9 This method consisted in the fusion of one equivalent of urea with one equivalent of 3-o-methoxyphenoxy-1,2-propanediol at 180-200 o C to produce the crude oxazolidinone which was further purified by fractional distillation and crystallization to gave a 67% isolated product yield. There are only a few reports in literature about the synthesis of Mephenoxalone. [10] [11] [12] [13] Previously, we reported the synthesis of a bronchodilator blocker Fenspiride (5) 14 and continuing our interest in cyclization reactions using bistrichloromethyl carbonate (BTC or triphosgene) and the addition of trimethylsilyl cyanide to aldehydes, 15 we proposed a new methodology for the synthesis of Mephenoxalone through silanized intermediate.
Results and Discussion
Our goals in this work were to synthesize Mephenoxalone by the addition of trimethylsilyl cyanide to (o-methoxy)phenoxyacetaldehyde (10) and compare the efficiency of different catalysts in the addition step. The aldehyde used as starting material is not commercially available and was necessary to be prepared. Three different methods were proposed for the synthesis of aldehyde 10 (Scheme 1). 1) Direct alkylation of guaiacol with chloroacetaldehyde under basic conditions with 26% yield. 2) Alkylation of guaiacol with ethyl bromoacetate using K 2 CO 3 in acetone followed by reduction of the corresponding ethyl (o-methoxy)phenoxyacetate (7) to obtain (o-methoxy)phenoxyethanol (8) . This alcohol was oxidized with PCC leading to the aldehyde 10. The overall yield with this method was 16%. 3) Alkylation of guaiacol with bromoacetaldehyde diethyl acetal, 25% NaOH aqueous solution and HMPA as solvent gave the (o-methoxy)phenoxyacetaldehyde diethyl acetal (9) which was hydrolyzed with HCl in 1,4-dioxane to gave the aldehyde 10. 16 The overall yield with this method was 49%. Comparing these results, we concluded that the best synthetic route was method 3 because required only two reaction steps and gave the highest overall yield. HCl Scheme 1. Synthesis of (o-methoxy)phenoxyacetaldehyde (10).
The addition of TMSCN to the aldehyde 10 was carried out with ZnI 2 , Montmorillonite K10, (+)-Eu(tfc) 3 and (+)-Yb(tfc) 3 in order to obtain the silanized intermediate 11 with good yield in each case (88-96%) (Scheme 2 and Table 1 ). Lanthanide reagents are frequently used in organic synthesis as catalysts in different reactions, [17] [18] [19] [20] [21] [22] but lanthanide camphorates are typically used as chiral shift reagents for direct determination enantiomeric compositions by nuclear magnetic resonance. [23] [24] [25] Here, europium and ytterbium camphorates were used to establish their catalytic capacity and asymmetric induction in the addition of TMSCN to the carbonyl group. They generated excellent activation in both cases, 96% and 88% yield respectively, but asymmetric induction was not observed. The silyl ether 11 was reduced using LiAlH 4 giving the β-aminoalcohol 12 with 63 % yield. 26 The final step consisted in the cyclization of 12 with BTC to give the oxazolidinone 1 in 70% yield (Scheme 2). The overall yield from aldehyde 10 to Mephenoxalone (1) was 42%.
1 H and 13 C NMR of this product were obtained and signals are in accordance with the date reported in literature. 27 
Conclusions
In summary, the process of addition of trimethylsilyl cyanide to aldehyde 10 allowed us to develop a new methodology to synthesize Mephenoxalone. This reaction occurs with very good yields using different catalysts and subsequent reduction and cyclization with BTC led to form (o-Methoxy)phenoxyacetaldehyde (10). (o-Methoxy)phenoxyethanol (1.00 g, 5.95 mmol) was dissolved in 40 mL of dichloromethane, pyridinium chlorochromate (7.70 g, 35.7 mmol) was added and the mixture was stirred for 24 hours at room temperature. The mixture was dissolved in ethyl ether and filtered over a silica gel pad and the solvent was evaporated to give a yellow solid (0.30 g, 1.79 mmol, 30% yield).
Method 3
(o-Methoxy)phenoxyacetaldehyde diethyl acetal (9) . Guaiacol (2.00 g, 16.1 mmol) was dissolved in 60 mL of HMPA, a NaOH aqueous solution (1.28 g, 32.2 mmol, 10 mL) was added drop wise and stirred at 0 o C for 15 minutes, bromoacetaldehyde diethyl acetal (3.00 g, 16.1 mmol) was added drop wise at 0 o C and the mixture was refluxed for 6 hours. The mixture was poured into 60 mL of a 5% HCl aqueous solution and and extracted with CH 2 Cl 2 (3 x 30 mL). The organic phase was separated and washed with water (2x 50 mL), dried over Na 2 SO 4 and filtered. 
